Antithrombin Market Size, Share, Trends, Growth and Forecast 2032

Antithrombin Market

Antithrombin Market by Source (Human and Goat Milk), Application (Diagnostics, Therapeutics, and Research), By Dosage Form (Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032.-

Category: Pharmaceutical Report Format : PDF Pages: 132 Report Code: ZMR-2514 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 617.08 Million USD 934.57 Million 4.72% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Source
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Dosage Form
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Antithrombin Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Antithrombin Market – Source Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Source, 2020 & 2028
    • 4.2. Human
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Goat Milk
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Antithrombin Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Diagnostics
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Therapeutics
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Research
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Antithrombin Market – Dosage Form Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Dosage Form, 2020 & 2028
    • 6.2. Liquid
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Lyophilized
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Antithrombin Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Source, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Dosage Form, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Source, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Dosage Form, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Source, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Dosage Form, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Source, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Dosage Form, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Source, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Source, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Source, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Application, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Source, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Source, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Source, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Dosage Form, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Source, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Dosage Form, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Source, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Source, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Application, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Source, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Source, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Application, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Source, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Source, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Dosage Form, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Source, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Dosage Form, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Source, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Dosage Form, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Source, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Dosage Form, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Source, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Dosage Form, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Source, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Dosage Form, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Source, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Dosage Form, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Source, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Dosage Form, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Source, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Dosage Form, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Source, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Dosage Form, 2016 – 2028
  • Chapter No. 8 Antithrombin Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Source Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Antithrombin Market: Company Market Share, 2019
      • 9.1.2. Global Antithrombin Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Antithrombin Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Antithrombin Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Grifuls
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. rEVO Biulogics Inc
    • 10.3. Shire plc
    • 10.4. Kedrion S.p.A
    • 10.5. CSL Limited
    • 10.6. Scripps Laboratories Inc
    • 10.7. Lee Biosulutions
    • 10.8. Company 8
    • 10.9. Company 9
    • 10.10. Company 10
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Application Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Source
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Antithrombin Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Source, 2020 & 2028
FIG NO. 8. Global Antithrombin Market for Human, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Antithrombin Market for Human, By Country, 2020 & 2028
FIG NO. 10. Global Antithrombin Market for Goat Milk, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Antithrombin Market for Goat Milk, By Country, 2020 & 2028
FIG NO. 12. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 13. Global Antithrombin Market for Diagnostics, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Antithrombin Market for Diagnostics, By Country, 2020 & 2028
FIG NO. 15. Global Antithrombin Market for Therapeutics, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Antithrombin Market for Therapeutics, By Country, 2020 & 2028
FIG NO. 17. Global Antithrombin Market for Research, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Antithrombin Market for Research, By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By Dosage Form, 2020 & 2028
FIG NO. 20. Global Antithrombin Market for Liquid, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Antithrombin Market for Liquid, By Country, 2020 & 2028
FIG NO. 22. Global Antithrombin Market for Lyophilized, Revenue (USD Million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Antithrombin Market for Lyophilized, By Country, 2020 & 2028
FIG NO. 24. Global Antithrombin Market Revenue Share, By Region, 2020 & 2028
FIG NO. 25. North America Antithrombin Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 26. Porter’s Five Forces Analysis for Global Antithrombin Market
FIG NO. 27. PEST Analysis for Global Antithrombin Market
FIG NO. 28. Pricing Analysis for Global Antithrombin Market
FIG NO. 29. Value Chain Analysis for Global Antithrombin Market
FIG NO. 30. Company Share Analysis, 2019
FIG NO. 31. Radar Determinant Chart, 2019
FIG NO. 32. Company Strategic Developments – Heat Map Analysis
FIG NO. 33. Grifols Business Segment Revenue Share, 2020 (%)
FIG NO. 34. Grifols Geographical Segment Revenue Share, 2020 (%)
FIG NO. 35. Market Channels
FIG NO. 36. Marketing Channel Development Trend
FIG NO. 37. Growth in World Gross Product, 2008-2018
FIG NO. 38. Research Methodology – Detailed View
FIG NO. 39. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Antithrombin Market: Snapshot
TABLE NO. 2. Quarterly Antithrombin Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Antithrombin Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Antithrombin Market for Human, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Antithrombin Market for Goat Milk, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Antithrombin Market for Diagnostics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Antithrombin Market for Therapeutics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Antithrombin Market for Research, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Antithrombin Market for Liquid, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Antithrombin Market for Lyophilized, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. G6obal Antithrombin Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Antithrombin Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Antithrombin Market Revenue, By Source, 2016 – 2028 (USD Million)
TABLE NO. 16. North America Antithrombin Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 17. North America Antithrombin Market Revenue, By Dosage Form, 2016 – 2028 (USD Million)
TABLE NO. 18. U.S. Antithrombin Market Revenue, By Source, 2016 – 2028 (USD Million)
TABLE NO. 19. U.S. Antithrombin Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 20. U.S. Antithrombin Market Revenue, By Dosage Form, 2016 – 2028 (USD Million)
TABLE NO. 21. Canada Antithrombin Market Revenue, By Source, 2016 – 2028 (USD Million)
TABLE NO. 22. Canada Antithrombin Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. Canada Antithrombin Market Revenue, By Dosage Form, 2016 – 2028 (USD Million)
TABLE NO. 24. Mexico Antithrombin Market Revenue, By Source, 2016 – 2028 (USD Million) 
TABLE NO. 25. Mexico Antithrombin Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. Mexico Antithrombin Market Revenue, By Dosage Form, 2016 – 2028 (USD Million)
TABLE NO. 27. Drivers for the Antithrombin Market: Impact Analysis
TABLE NO. 28. Restraints for the Antithrombin Market: Impact Analysis
TABLE NO. 29. Major Buyers of Antithrombin 
TABLE NO. 30. Distributors/Traders List of Antithrombin 
TABLE NO. 31. Global Antithrombin Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 32. Global Antithrombin Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 
 

Methodology

FrequentlyAsked Questions

Antithrombin Market size is set to expand from $ 617.08 Million in 2023

 $ 934.57 Million by 2032, with an anticipated CAGR of around 4.72% from 2024 to 2032

Some of the key factors driving the global Antithrombin market growth are Increasing Number of Surgical Procedures and Technological Advancement.

Europe is anticipated to remain the leading region over the forecast period. The rising adoption of antithrombin therapies owing to high awareness in the region is expected to boost the growth of the market in Europe.

The key dominant player’s operative in global Antithrombin market Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.  

Choose License Type

  • zion payment modes

List of Contents

Market InsightsMarket Overview Growth Factors Report ScopeSource Segment Analysis Preview Key Market Players Competitive LandscapeThe global market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed